Adaptive Immune Response to COVID-19 Vaccination

NCT04826770 · clinicaltrials.gov ↗

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV-2 Vaccination

Interventions

DRUG: BNT162b2
DRUG: AZD 1222
DRUG: mRNA-1273

Sponsor

University Medicine Greifswald